Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition for delaying progress of degenerative disease

A technology for degenerative diseases and compositions, applied in the field of compositions that delay the progress of degenerative diseases, can solve problems such as drug toxicity and side effects, and achieve the effects of delaying progress, improving quality of life, and increasing overall function

Active Publication Date: 2015-03-18
SHIJIAZHUANG KANGNUO BIOTECH
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, there is no clinical drug that can effectively delay the progress of degenerative diseases and improve the memory and cognitive dysfunction of patients, and the drugs often have different degrees of toxic and side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition for delaying progress of degenerative disease
  • Composition for delaying progress of degenerative disease
  • Composition for delaying progress of degenerative disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Embodiment 1. According to the ratio of royal jelly acid: gamma-aminobutyric acid=2.5:1, royal jelly acid and gamma-aminobutyric acid are weighed accurately. Royal jelly acid 125mg, gamma-aminobutyric acid 50mg.

Embodiment 2

[0024] Example 2, 100g royal jelly acid, 100g gamma-aminobutyric acid and 200g starch were fully mixed and pressed into tablets, each tablet was 200mg, wherein each tablet contained 50mg royal jelly acid and 50mg gamma-aminobutyric acid.

Embodiment 3

[0025] Embodiment 3. According to the ratio of calcium royal jelly: γ-aminobutyric acid=1:2.5, calcium royal jelly and γ-aminobutyric acid are weighed accurately, after fully mixing, put into hard capsules, each capsule contains 175 mg, and each The capsules contain 40mg of royal jelly acid and 125mg of gamma-aminobutyric acid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a composition for delaying progress of a degenerative disease. For solving the technical problem that the effect of delaying the progress of the degenerative disease by an existing medicament is not good, the adopted technical scheme is as follows: the composition comprises royal jelly acid or a royal jelly acid derivative and gamma-aminobutyric acid or a gamma-aminobutyric acid derivative, and the ratio in parts by weight is (0.1-10): (0-100). The composition has the technical effects that royal jelly acid or the royal jelly acid derivative and gamma-aminobutyric acid or the gamma-aminobutyric acid derivative can play respective roles and simultaneously realize mutual synergy, thereby effectively delaying the progress of the degenerative disease, significantly improving memory and cognitive dysfunction of a patient with the degenerative disease and improving the quality of life of the patient (P<0.01).

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical products, and relates to a composition, in particular to a composition for delaying the progress of degenerative diseases. Background technique [0002] A degenerative disease is a disease state in which cells and neurons of the brain and spinal cord are lost. The brain and spinal cord are made up of neurons that have different functions, such as controlling movement, processing sensory information, and making decisions. Cells in the brain and spinal cord generally do not regenerate, so excessive damage can be devastating and irreversible. Degenerative diseases are caused by the loss of neurons or their myelin sheath, which worsens over time, leading to dysfunction. Degenerative diseases include Alzheimer's disease (AD), amyotrophic lateral sclerosis, Parkinson's disease, cerebellar atrophy, Huntington's disease, Creutzfeldt-Jakob disease, multiple sclerosis, etc. Among them, Alzheimer's ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/201A61P25/28A61P25/00A61K31/197
CPCA61K31/197A61K31/201A61K2300/00
Inventor 赵瑞林赵玮璇张良才王家浩储德勇周宝梅李兵群
Owner SHIJIAZHUANG KANGNUO BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com